← Open Payments lookup

SARA BAILEY: Open Payments

NPI 1699381368 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$517 in 20 payments from 9 companies in 2025. Trend: 2023 $1,492 · 2024 $1,434 · 2025 $517

Food & beverage: $517
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$189
ABBVIE INC.3$71
Otsuka America Pharmaceutical, Inc.3$67
Teva Pharmaceuticals USA, Inc.3$60
Alkermes, Inc.2$38
Takeda Pharmaceuticals U.S.A., Inc.2$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Axsome Therapeutics, Inc.1$19
Collegium Pharmaceutical, Inc.1$17

Products named: INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, UZEDY, ARISTADA, TRINTELLIX, CAPLYTA, REXULTI.

Industry payments across OH — which companies pay providers there.